A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses
There is an urgent need for monoclonal antibody (mAb) therapies that broadly protect
against Ebola virus and other filoviruses. The conserved, essential interaction between the …
against Ebola virus and other filoviruses. The conserved, essential interaction between the …
[PDF][PDF] Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
Alphaviruses are emerging, mosquito-transmitted pathogens that cause musculoskeletal
and neurological disease in humans. Although neutralizing antibodies that inhibit individual …
and neurological disease in humans. Although neutralizing antibodies that inhibit individual …
Peptide-based vaccines: current progress and future challenges
RJ Malonis, JR Lai, O Vergnolle - Chemical reviews, 2019 - ACS Publications
Vaccines have had a profound impact on the management and prevention of infectious
disease. In addition, the development of vaccines against chronic diseases has attracted …
disease. In addition, the development of vaccines against chronic diseases has attracted …
[HTML][HTML] Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses
Experimental monoclonal antibody (mAb) therapies have shown promise for treatment of
lethal Ebola virus (EBOV) infections, but their species-specific recognition of the viral …
lethal Ebola virus (EBOV) infections, but their species-specific recognition of the viral …
[PDF][PDF] A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition
There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19.
Rapid SARS-CoV-2 countermeasure development is contingent on the availability of robust, …
Rapid SARS-CoV-2 countermeasure development is contingent on the availability of robust, …
[PDF][PDF] Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
Antibodies are promising post-exposure therapies against emerging viruses, but which
antibody features and in vitro assays best forecast protection are unclear. Our international …
antibody features and in vitro assays best forecast protection are unclear. Our international …
Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes
MA Fischbach, JR Lai, ED Roche… - Proceedings of the …, 2007 - National Acad Sciences
Nonribosomal peptides (NRPs) are produced by NRP synthetase (NRPS) enzymes that
function as molecular assembly lines. The modular architecture of NRPSs suggests that a …
function as molecular assembly lines. The modular architecture of NRPSs suggests that a …
Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo
Chikungunya virus (CHIKV) has recently emerged to cause millions of human infections
worldwide. Infection can induce the formation of long intercellular extensions that project from …
worldwide. Infection can induce the formation of long intercellular extensions that project from …
Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial
…, R Mathew, B Patel, M Nigo, R Upadhyay… - JAMA internal …, 2022 - jamanetwork.com
Importance There is clinical equipoise for COVID-19 convalescent plasma (CCP) use in
patients hospitalized with COVID-19. Objective To determine the safety and efficacy of CCP …
patients hospitalized with COVID-19. Objective To determine the safety and efficacy of CCP …
Protocadherin-1 is essential for cell entry by New World hantaviruses
The zoonotic transmission of hantaviruses from their rodent hosts to humans in North and
South America is associated with a severe and frequently fatal respiratory disease, hantavirus …
South America is associated with a severe and frequently fatal respiratory disease, hantavirus …